$36.31
0.711.99%
At close: -
$36.31
0.000.00%
After Hours: 4:58 PM EDT
Comments
Loading...
CRISPR Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CRSP | Benzinga
CRISPR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS
$-1.580
Quarterly Revenue
$865.00K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$35.00M
Analyze the earnings history of CRISPR Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics | -$1.49 | — | — | — | $517.00K | — | — | — | 08/04/2025 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.43 | -$1.25 | -$1.58 | -26.40% | $504.00K | $6.39M | $865.00K | -86.46% | 05/06/2025 | Get Alert |
| CRSP | CRISPR Therapeutics | $1.10 | -$1.21 | -$0.44 | 63.64% | $201.21M | $7.38M | $35.69M | 383.62% | 02/11/2025 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.41 | -$1.42 | -$1.01 | 28.87% | $0.00 | $6.81M | $602.00K | -91.16% | 11/05/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.98 | -$1.52 | -$1.49 | 1.97% | $70.00M | $3.54M | $517.00K | -85.40% | 08/05/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.67 | -$1.42 | -$1.43 | -0.70% | $100.00M | $28.11M | $504.00K | -98.21% | 05/08/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.41 | -$0.07 | $1.10 | 1671.43% | $6.00K | $131.63M | $201.21M | 52.86% | 02/21/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.24 | -$1.96 | -$1.41 | 28.06% | $94.00K | $8.43M | $0.00 | -100.00% | 11/06/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.40 | -$2.12 | -$0.98 | 53.77% | $158.00K | $1.71M | $70.00M | 3993.57% | 08/07/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.32 | -$1.70 | -$0.67 | 60.59% | $940.00K | $22.98M | $100.00M | 335.16% | 05/08/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.84 | -$2.30 | -$1.41 | 38.70% | $12.90M | $7.12M | $6.00K | -99.92% | 02/21/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.67 | -$2.29 | -$2.24 | 2.18% | $824.00K | $1.62M | $94.00K | -94.20% | 11/01/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | $9.44 | -$2.23 | -$2.40 | -7.62% | $900.70M | $2.06M | $158.00K | -92.33% | 08/08/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.51 | — | -$2.32 | — | $539.00K | — | $940.00K | — | 05/09/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.50 | -$1.77 | -$1.84 | -3.95% | $370.00K | $2.27M | $12.90M | 468.24% | 02/15/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.32 | -$1.76 | -$1.67 | 5.11% | $148.00K | $1.12M | $824.00K | -26.43% | 11/03/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.30 | $3.52 | $9.44 | 168.18% | $44.00K | $420.92M | $900.70M | 113.98% | 07/29/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.15 | -$1.47 | -$1.51 | -2.72% | $157.00K | $1.14M | $539.00K | — | 04/27/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | $0.51 | -$1.27 | -$1.50 | -18.11% | $77.02M | $2.32M | $370.00K | -84.05% | 02/16/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | $2.40 | -$1.18 | -$1.32 | -11.86% | $211.93M | $2.06M | $148.00K | -92.82% | 10/28/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.01 | -$0.95 | -$1.30 | -36.84% | $318.00K | $18.12M | $44.00K | -99.76% | 07/27/2020 | Get Alert |
CRISPR Therapeutics (CRSP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-06 | $-1.58 | $-1.25 | -26.4 % |
| Q4 | 2025-02-11 | $-0.44 | $-1.21 | 63.6 % |
| Q3 | 2024-11-05 | $-1.01 | $-1.42 | 28.9 % |
| Q2 | 2024-08-05 | $-1.49 | $-1.52 | 1.97 % |
CRISPR Therapeutics (CRSP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-06 | $865.00K | $6.39M | -86.5 % |
| Q4 | 2025-02-11 | $35.69M | $7.38M | 383.6 % |
| Q3 | 2024-11-05 | $602.00K | $6.81M | -91.2 % |
| Q2 | 2024-08-05 | $517.00K | $3.54M | -85.4 % |
FAQ
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
CRISPR Therapeutics (CRSP) is scheduled to report earnings on August 4, 2025. The last reported earnings were for reported on May 6, 2025 for Q1.
What were the latest earnings per share (EPS) for CRISPR Therapeutics (NASDAQ:CRSP)?
The Actual EPS was $-1.58, which missed the estimate of $-1.25.
What were CRISPR Therapeutics’s (NASDAQ:CRSP) revenues?
The Actual Revenue was $865K, which missed the estimate of $6.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
